SAN DIEGO (AP) — SAN DIEGO (AP) — Cardiff Oncology, Inc. (CRDF) on Thursday reported a loss of $11.9 million in its third quarter.
On a per-share basis, the San Diego-based company said it had a loss of 25 cents.
The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 27 cents per share.
The molecular diagnostic company posted revenue of $165,000 in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CRDF at https://www.zacks.com/ap/CRDF
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
